Outset Medical, Inc. Restructuring Charges
Outset Medical, Inc. (OM) reported Restructuring Charges of $34.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-02-13
- Outset Medical, Inc. restructuring charges for the quarter ending 2025-12-31 was $0.00.
- Outset Medical, Inc. restructuring charges for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Outset Medical, Inc. restructuring charges for the quarter ending 2025-06-30 was $0.00.
- Outset Medical, Inc. restructuring charges for the quarter ending 2025-03-31 was $34.00K, a 98.85% decline year-over-year.
- Outset Medical, Inc. restructuring charges for fiscal 2025 was $34.00K.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | $34.00K 10-K · filed 2026-02-13 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $34.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $34.00K 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | $34.00K 10-Q · filed 2025-05-08 | |||
| 2024-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.19M derived: sum of 2 quarters · filed 2024-11-07 | $4.15M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.78M 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | $2.96M 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |